A Study of a New Approach for Assessing Immune Function

Overview

About this study

The immune system is central to most areas of medicine. Understanding how the immune system responds to disease is important for improving care for patients. Knowledge gained from this study may lead to the development of new tests for patients. When combined with other studies, it will lead to a better understanding of the immune response to tumors, allergic and infectious agents, and to self. This, in turn, will aid in the design of new strategies to preserve health and treat disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Healthy human subjects at least 18 years of age 
  • Able to give written consent 
  • No known allergies, autoimmune disease, immunodeficiencies or cancer. 
  • Subjects should not be pregnant  
  • Should not be on systemic (oral) corticosteroids.  

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Larry Pease, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions